Global Infectious Bursal Disease Vaccine Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

The Infectious Bursal Disease Vaccine Market anticipates to grow in terms of USD Million / Billion during forecast period of 2026 to 2035. The expected CAGR for the Infectious Bursal Disease Vaccine market growth is XX%. The reports published by the Extent Research offer comprehensive analysis about the markets with its size and forecast which are completely reliable. Every report provides the growth drivers, restraints, opportunities, and challenges coupled with detailed vendor analysis covering over 20 vendors functioning in the industry.

Data provided by Extent Research. Source: https://www.extentresearch.com/infectious-bursal-disease-vaccine-market

The current report on the Global Infectious Bursal Disease Vaccine Market provides the current market scenario the trends that are driving the Infectious Bursal Disease Vaccine market and the overall complete Infectious Bursal Disease Vaccine market scenario. The primary factor that is driving the Infectious Bursal Disease Vaccine market growth is the increasing product demand by the en-user industries. Increasing investments by the market players to upgrade their product portfolio helps the market growth on the global platform.

The Infectious Bursal Disease Vaccine market analysis includes the product type, application, and the regional segmentation.

By Type

Live, Inactivated,

By Application/ End-user

Veterinary Pharmacy, Online Sale, Others,

By Geographic Landscape

Asia Pacific
North America
Europe
Latin America
Middle East and Africa

The report on the Infectious Bursal Disease Vaccine market represents a detailed information about market, which was conducted by studying, synthesizing, and summating the data from various reliable resources keeping in mind a series of key parameters.

The Global Infectious Bursal Disease Vaccine Market Research Study includes:

Infectious Bursal Disease Vaccine market sizing
Infectious Bursal Disease Vaccine market forecast
Infectious Bursal Disease Vaccine market industry analysis

This robust vendor analysis towards the end of the Global Infectious Bursal Disease Vaccine market report is specifically designed to help the clients analyze and improvise their market position on the global platform. The major market players that are functioning in this industry are Zoetis, Merck, Elanco, Boehringer Ingelheim, Ceva, Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Plyco Bioengineering Co., Ltd., Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd., . All the manufacturers, dealers, retailers that are operating in the Infectious Bursal Disease Vaccine market are profiled in detail in the report. At the end of the report there is conclusion section, where all the important observations by the research analysts have been included along with the market expert opinions about the market growth, segmental growth, and regional opportunities are all penned in-detail.

Report Scope and Market Segmentation

ATTRIBUTES	Global Infectious Bursal Disease Vaccine Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Infectious Bursal Disease Vaccine Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Infectious Bursal Disease Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Infectious Bursal Disease Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Live
        1.2.3 Inactivated
    1.3 Market by Application
        1.3.1 Global Infectious Bursal Disease Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Veterinary Pharmacy
        1.3.3 Online Sale
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Infectious Bursal Disease Vaccine Sales Estimates and Forecasts 2017-2035
    2.2 Global Infectious Bursal Disease Vaccine Revenue Estimates and Forecasts 2017-2035
    2.3 Global Infectious Bursal Disease Vaccine Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Infectious Bursal Disease Vaccine Sales by Region
        2.4.1 Global Infectious Bursal Disease Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Infectious Bursal Disease Vaccine by Region (2023-2035)
    2.5 Global Infectious Bursal Disease Vaccine Revenue by Region
        2.5.1 Global Infectious Bursal Disease Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Infectious Bursal Disease Vaccine Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Infectious Bursal Disease Vaccine Sales by Manufacturers
        3.1.1 Global Top Infectious Bursal Disease Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Infectious Bursal Disease Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Infectious Bursal Disease Vaccine in 2021
    3.2 Global Infectious Bursal Disease Vaccine Revenue by Manufacturers
        3.2.1 Global Infectious Bursal Disease Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Infectious Bursal Disease Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Infectious Bursal Disease Vaccine Revenue in 2021
    3.3 Global Infectious Bursal Disease Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Infectious Bursal Disease Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Infectious Bursal Disease Vaccine Sales by Type
        4.1.1 Global Infectious Bursal Disease Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Infectious Bursal Disease Vaccine Forecasted Sales by Type (2023-2035)
        4.1.3 Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2017-2035)
    4.2 Global Infectious Bursal Disease Vaccine Revenue by Type
        4.2.1 Global Infectious Bursal Disease Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Infectious Bursal Disease Vaccine Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2017-2035)
    4.3 Global Infectious Bursal Disease Vaccine Price by Type
        4.3.1 Global Infectious Bursal Disease Vaccine Price by Type (2017-2022)
        4.3.2 Global Infectious Bursal Disease Vaccine Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Infectious Bursal Disease Vaccine Sales by Application
        5.1.1 Global Infectious Bursal Disease Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Infectious Bursal Disease Vaccine Forecasted Sales by Application (2023-2035)
        5.1.3 Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2017-2035)
    5.2 Global Infectious Bursal Disease Vaccine Revenue by Application
        5.2.1 Global Infectious Bursal Disease Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Infectious Bursal Disease Vaccine Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2017-2035)
    5.3 Global Infectious Bursal Disease Vaccine Price by Application
        5.3.1 Global Infectious Bursal Disease Vaccine Price by Application (2017-2022)
        5.3.2 Global Infectious Bursal Disease Vaccine Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Infectious Bursal Disease Vaccine Market Size by Type
        6.1.1 North America Infectious Bursal Disease Vaccine Sales by Type (2017-2035)
        6.1.2 North America Infectious Bursal Disease Vaccine Revenue by Type (2017-2035)
    6.2 North America Infectious Bursal Disease Vaccine Market Size by Application
        6.2.1 North America Infectious Bursal Disease Vaccine Sales by Application (2017-2035)
        6.2.2 North America Infectious Bursal Disease Vaccine Revenue by Application (2017-2035)
    6.3 North America Infectious Bursal Disease Vaccine Market Size by Country
        6.3.1 North America Infectious Bursal Disease Vaccine Sales by Country (2017-2035)
        6.3.2 North America Infectious Bursal Disease Vaccine Revenue by Country (2017-2035)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Infectious Bursal Disease Vaccine Market Size by Type
        7.1.1 Europe Infectious Bursal Disease Vaccine Sales by Type (2017-2035)
        7.1.2 Europe Infectious Bursal Disease Vaccine Revenue by Type (2017-2035)
    7.2 Europe Infectious Bursal Disease Vaccine Market Size by Application
        7.2.1 Europe Infectious Bursal Disease Vaccine Sales by Application (2017-2035)
        7.2.2 Europe Infectious Bursal Disease Vaccine Revenue by Application (2017-2035)
    7.3 Europe Infectious Bursal Disease Vaccine Market Size by Country
        7.3.1 Europe Infectious Bursal Disease Vaccine Sales by Country (2017-2035)
        7.3.2 Europe Infectious Bursal Disease Vaccine Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Infectious Bursal Disease Vaccine Market Size by Type
        8.1.1 Asia Pacific Infectious Bursal Disease Vaccine Sales by Type (2017-2035)
        8.1.2 Asia Pacific Infectious Bursal Disease Vaccine Revenue by Type (2017-2035)
    8.2 Asia Pacific Infectious Bursal Disease Vaccine Market Size by Application
        8.2.1 Asia Pacific Infectious Bursal Disease Vaccine Sales by Application (2017-2035)
        8.2.2 Asia Pacific Infectious Bursal Disease Vaccine Revenue by Application (2017-2035)
    8.3 Asia Pacific Infectious Bursal Disease Vaccine Market Size by Region
        8.3.1 Asia Pacific Infectious Bursal Disease Vaccine Sales by Region (2017-2035)
        8.3.2 Asia Pacific Infectious Bursal Disease Vaccine Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Infectious Bursal Disease Vaccine Market Size by Type
        9.1.1 Latin America Infectious Bursal Disease Vaccine Sales by Type (2017-2035)
        9.1.2 Latin America Infectious Bursal Disease Vaccine Revenue by Type (2017-2035)
    9.2 Latin America Infectious Bursal Disease Vaccine Market Size by Application
        9.2.1 Latin America Infectious Bursal Disease Vaccine Sales by Application (2017-2035)
        9.2.2 Latin America Infectious Bursal Disease Vaccine Revenue by Application (2017-2035)
    9.3 Latin America Infectious Bursal Disease Vaccine Market Size by Country
        9.3.1 Latin America Infectious Bursal Disease Vaccine Sales by Country (2017-2035)
        9.3.2 Latin America Infectious Bursal Disease Vaccine Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
        9.3.6 Colombia
10 Middle East and Africa
    10.1 Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Type
        10.1.1 Middle East and Africa Infectious Bursal Disease Vaccine Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Type (2017-2035)
    10.2 Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Application
        10.2.1 Middle East and Africa Infectious Bursal Disease Vaccine Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Application (2017-2035)
    10.3 Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Country
        10.3.1 Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Zoetis
        11.1.1 Zoetis Corporation Information
        11.1.2 Zoetis Overview
        11.1.3 Zoetis Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Zoetis Infectious Bursal Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Zoetis Recent Developments
    11.2 Merck
        11.2.1 Merck Corporation Information
        11.2.2 Merck Overview
        11.2.3 Merck Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Merck Infectious Bursal Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Merck Recent Developments
    11.3 Elanco
        11.3.1 Elanco Corporation Information
        11.3.2 Elanco Overview
        11.3.3 Elanco Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Elanco Infectious Bursal Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Elanco Recent Developments
    11.4 Boehringer Ingelheim
        11.4.1 Boehringer Ingelheim Corporation Information
        11.4.2 Boehringer Ingelheim Overview
        11.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Boehringer Ingelheim Recent Developments
    11.5 Ceva
        11.5.1 Ceva Corporation Information
        11.5.2 Ceva Overview
        11.5.3 Ceva Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Ceva Infectious Bursal Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Ceva Recent Developments
    11.6 Qingdao Yibang Biological Engineering Co., Ltd.
        11.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Corporation Information
        11.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Overview
        11.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments
    11.7 Shandong Lvdu Biological Technology Co., Ltd.
        11.7.1 Shandong Lvdu Biological Technology Co., Ltd. Corporation Information
        11.7.2 Shandong Lvdu Biological Technology Co., Ltd. Overview
        11.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Shandong Lvdu Biological Technology Co., Ltd. Recent Developments
    11.8 Plyco Bioengineering Co., Ltd.
        11.8.1 Plyco Bioengineering Co., Ltd. Corporation Information
        11.8.2 Plyco Bioengineering Co., Ltd. Overview
        11.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Plyco Bioengineering Co., Ltd. Recent Developments
    11.9 Ruipu Biopharmaceutical Co., Ltd.
        11.9.1 Ruipu Biopharmaceutical Co., Ltd. Corporation Information
        11.9.2 Ruipu Biopharmaceutical Co., Ltd. Overview
        11.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments
    11.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
        11.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Corporation Information
        11.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Overview
        11.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Infectious Bursal Disease Vaccine Industry Chain Analysis
    12.2 Infectious Bursal Disease Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Infectious Bursal Disease Vaccine Production Mode & Process
    12.4 Infectious Bursal Disease Vaccine Sales and Marketing
        12.4.1 Infectious Bursal Disease Vaccine Sales Channels
        12.4.2 Infectious Bursal Disease Vaccine Distributors
    12.5 Infectious Bursal Disease Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Infectious Bursal Disease Vaccine Industry Trends
    13.2 Infectious Bursal Disease Vaccine Market Drivers
    13.3 Infectious Bursal Disease Vaccine Market Challenges
    13.4 Infectious Bursal Disease Vaccine Market Restraints
14 Key Findings in The Global Infectious Bursal Disease Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Infectious Bursal Disease Vaccine Market